Can Fite Biofarma Ltd.

13F holders, Q2 2024 (June 30)
11holders +3
5new positions
2sold out
$2.58avg. 13F price*

At the end of Q2 2024, 11 institutions reported holding Can Fite Biofarma Ltd. in their 13F filings, up 3 from Q1 2024. 5 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($1.3M), Morgan Stanley ($175K) and Rhumbline Advisers ($40K).

Company
Can Fite Biofarma Ltd.
CUSIP
13471N300
Latest filing quarter
Q4 2025

History

Number of 13F holders

05101520 Q1 2024: 8Q1 2024Q2 2024: 11Q2 2024Q3 2024: 12Q3 2024Q4 2024: 13Q4 2024Q1 2025: 14Q1 2025Q2 2025: 16Q2 2025Q3 2025: 16Q3 2025Q4 2025: 15Q4 2025

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions5$55K
Exits2$36K

All 13F filers, Q1 2024 → Q2 2024: 169,667 shares bought and 19,427 shares sold, net +150,240 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 11 holders

Armistice Capital, LLC 0.04% Add +35.5% 518,853 $1.3M
Morgan Stanley 0.00% Add +21.5% 67,807 $175K
Rhumbline Advisers 0.00% Reduce -16.7% 15,398 $40K
Virtu Financial LLC 0.00% New 10,417 $27K
HRT Financial LP 0.00% New 10,790 $27K
Fifth Third Bancorp 0.00% No change 3,000 $8K
National Bank of Canada 0.00% No change 600 $2K
Citigroup Inc. 0.00% No change 553 $1K
Activest Wealth Management 0.00% New 200 $516
Osaic Holdings, Inc. 0.00% New 185 $477
TD Waterhouse Canada Inc. 0.00% New 20 $52

"% of holder's portfolio" is CAN FITE BIOFARMA LTD's weight in each manager's 13F, not the share of Can Fite Biofarma Ltd. the manager owns.